Apta-2

Apta-2 is being developed within the inflammation area and has been manufactured in a small scale for initial studies. However, it is too early to draw any conclusions, other than a potential promising profile.

Pipeline

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Apta-2

Under evaluation within inflammation